BioLamina vs CTIBIOTECH USA

BioLamina vs CTIBIOTECH USA, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioLamina is on 45/100 and CTIBIOTECH USA on 46/100.

BioLamina logo
BioLaminaDeveloping and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.
Try BioLamina
CTIBIOTECH USA logo
CTIBIOTECH USANorth American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.
Try CTIBIOTECH USA

Where each one leads

BioLamina

  • domain rating: 37/100 against 30/100
  • funding raised: $41.9M against $4.3M

CTIBIOTECH USA

  • agent readiness: 50/100 against 21/100

At a glance

MeasureBioLaminaCTIBIOTECH USA
What it isDeveloping and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.
CategoryBiotechnology, Life Sciences, HealthTech, Cell TherapyBiotechnology, Healthcare, 3D Printing, Regenerative Medicine
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20092024
HeadquartersStockholm, SwedenPhiladelphia, USA
StatusActiveActive

Size, funding and growth

MeasureBioLaminaCTIBIOTECH USA
EmployeesNot published22
Total funding$41.9M$4.3M
Latest roundVenture DebtUndisclosed
LinkedIn followersNot published7,543

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureBioLaminaCTIBIOTECH USA
StartupHub scoreOur 0-100 rating45/10046/100
Traction38/10047/100
Team30/100Not published
Search visibility15/10031/100
Quality58/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (50/100)
Domain ratingLink authority, 0-10037/10030/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureBioLaminaCTIBIOTECH USA
CMSWordPressNot detected
FrameworksJqueryAstro
AnalyticsGoogle Analytics 4, Google Tag ManagerNot detected
Support stackHubSpotNot detected

BioLamina vs CTIBIOTECH USA: common questions

Which is better, BioLamina or CTIBIOTECH USA?

On our 0-100 score CTIBIOTECH USA rates higher (46/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do BioLamina and CTIBIOTECH USA compare on the numbers?

BioLamina leads on domain rating (37/100 against 30/100), funding raised ($41.9M against $4.3M). CTIBIOTECH USA leads on agent readiness (50/100 against 21/100).

Read the full BioLamina review and pricing or the CTIBIOTECH USA review and pricing. You can also browse other BioLamina alternatives we track.